PROTEOMICS PROFILING OF BREAST CANCER PATIENTS RECEIVING TAMOXIFEN

被引：0
|
作者：
Johansson, H. J. [2 ]
Sanchez, B. Chavez [1 ]
Bergh, J. [3 ,4 ,5 ]
Linderholm, B.
Lehtio, J.
机构：
[1] Karolinska Inst, Dept Oncol Pathol, KBC, Stockholm, Sweden
[2] Univ Hosp, KBC, Stockholm, Sweden
[3] Karolinska Hosp, Clin & Translat Res, S-10401 Stockholm, Sweden
[4] Univ Manchester, Manchester, Lancs, England
[5] Christie Med Oncol Breast Unit, Manchester, Lancs, England
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
70P
引用
收藏
页码：41 / 41
页数：1
相关论文
共 50 条
  • [21] Profiling metabolic changes in breast cancer with targeted proteomics
    Stephan Bernhardt
    Devina Mitra
    Zita Soons
    Rainer König
    Martina Vetter
    Christoph Thomssen
    Eva Kantelhardt
    Stefan Wiemann
    Ulrike Korf
    [J]. Cancer & Metabolism, 2 (Suppl 1)
  • [22] SENSORY PERCEPTIONS OF WOMEN RECEIVING TAMOXIFEN FOR BREAST-CANCER
    MCDANIEL, RW
    RHODES, VA
    NELSON, RA
    HANSON, BM
    [J]. CANCER NURSING, 1995, 18 (03) : 215 - 221
  • [23] ENDOMETRIAL PATHOLOGY IN ASYMPTOMATIC WOMEN RECEIVING TAMOXIFEN FOR BREAST CANCER
    Aboulnasr, A.
    El Din, I. Saad
    Salem, M.
    Moety, G. Abdel
    Elmahy, M.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1012 - 1012
  • [24] MYELOSUPPRESSION OCCURRING AFTER RECEIVING TAMOXIFEN FOR BREAST-CANCER
    不详
    [J]. BRITISH JOURNAL OF RADIOLOGY, 1985, 58 (696): : 1220 - 1220
  • [25] Complications of tamoxifen in breast cancer patients
    Haghighat, S
    Ansari, M
    Akbari, M
    Kaviani, A
    Hashemi, E
    Ebrahimi, M
    Fakhrejahani, E
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 : S135 - S135
  • [26] The endometrium in breast cancer patients on tamoxifen
    Dallenbach-Hellweg, G
    Schmidt, D
    Hellberg, P
    Bourne, T
    Kreuzwieser, E
    Dören, M
    Rydh, W
    Rudenstam, G
    Granberg, S
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2000, 263 (04) : 170 - 177
  • [27] Tamoxifen therapy for patients with breast cancer
    Neven, Patrick
    Joensuu, Heikki
    Osborne, Kent
    Cardoso, Fatima
    Loibl, Sybille
    Linn, Sabine
    Goldhirsch, Aaron
    Ortmann, Olaf
    Senn, Hans Joerg
    Hayes, Daniel F.
    [J]. LANCET, 2013, 381 (9883): : 2078 - 2078
  • [28] The endometrium in breast cancer patients on tamoxifen
    G. Dallenbach-Hellweg
    D. Schmidt
    P. Hellberg
    T. Bourne
    E. Kreuzwieser
    M. Dören
    W. Rydh
    G. Rudenstam
    S. Granberg
    [J]. Archives of Gynecology and Obstetrics, 2000, 263 : 170 - 177
  • [29] Splice variant profiling in relation to tamoxifen resistance in breast cancer
    Zhang, L. D.
    Chan, Y. K.
    Ip, Y. C.
    Tsang, W. H.
    Cheung, Y. N.
    Wong, S. Y.
    Khoo, U. S.
    [J]. EJC SUPPLEMENTS, 2010, 8 (05): : 62 - 62
  • [30] Assessment of tamoxifen drug compliance by serum metabolite profiling in premenopausal breast cancer patients.
    Schroth, Werner
    Muerdter, Thomas
    Ganchev, Bolan
    Saladores, Pilar
    Eccles, Bryony
    Lo, Wing-Yee
    Precht, Jana C.
    Schwab, Matthias
    Potter, Kathy
    Eccles, Diana M.
    Brauch, Hiltrud B.
    [J]. CANCER RESEARCH, 2013, 73 (08)
12345